SafeBeat Rx

About SafeBeat Rx

SafeBeat Rx develops a mobile platform that utilizes artificial intelligence to enhance remote patient monitoring for cardiac care through FDA-cleared devices like mobile ECGs and implantable monitors. The technology provides clinicians with actionable insights and treatment recommendations, improving patient management and access to care for heart rhythm disorders.

<problem> Managing cardiac patients with heart rhythm disorders often requires frequent monitoring using devices like mobile ECGs and implantable monitors, which can be cumbersome and generate a high volume of data. Clinicians face challenges in efficiently analyzing this data to derive actionable insights and personalize treatment plans. Current remote patient monitoring solutions may not fully integrate with clinical workflows or provide therapeutic guidance. </problem> <solution> SafeBeat Rx offers a mobile platform that leverages artificial intelligence to streamline remote patient monitoring and enhance cardiac care. The platform integrates data from third-party FDA-cleared cardiac monitoring devices, including mobile ECGs, mobile cardiac telemetry, and implantable cardiac monitors. SafeBeat's AI algorithms analyze the data to provide clinicians with actionable insights and treatment recommendations, facilitating efficient patient management and improved access to care. The technology is designed to integrate into existing clinical workflows, offering explainable AI and customized tools that recommend treatment steps tailored to the patient. </solution> <features> - AI-powered analysis of data from mobile ECGs, mobile cardiac telemetry, and implantable cardiac monitors - Mobile platform designed for use on smartphones - Explainable AI that provides clinicians with clear insights and treatment recommendations - Software-enabled remote therapeutic monitoring (RTM) - Streamlined workflow integration to enhance patient monitoring and generate billing opportunities </features> <target_audience> The primary target audience includes cardiologists, electrophysiologists, and other healthcare providers involved in the management of patients with heart rhythm disorders. </target_audience>

What does SafeBeat Rx do?

SafeBeat Rx develops a mobile platform that utilizes artificial intelligence to enhance remote patient monitoring for cardiac care through FDA-cleared devices like mobile ECGs and implantable monitors. The technology provides clinicians with actionable insights and treatment recommendations, improving patient management and access to care for heart rhythm disorders.

Where is SafeBeat Rx located?

SafeBeat Rx is based in San Francisco, United States.

When was SafeBeat Rx founded?

SafeBeat Rx was founded in 2020.

How much funding has SafeBeat Rx raised?

SafeBeat Rx has raised 135000.

Location
San Francisco, United States
Founded
2020
Funding
135000
Employees
25 employees
Major Investors
Y Combinator, Liquid 2 Ventures, LG Nova, MedTech Innovator

Find Investable Startups and Competitors

Search thousands of startups using natural language

SafeBeat Rx

⚠️ AI-generated overview based on web search data – may contain errors, please verify information yourself! You can claim this account with your email domain to make edits.

Executive Summary

SafeBeat Rx develops a mobile platform that utilizes artificial intelligence to enhance remote patient monitoring for cardiac care through FDA-cleared devices like mobile ECGs and implantable monitors. The technology provides clinicians with actionable insights and treatment recommendations, improving patient management and access to care for heart rhythm disorders.

safebeat.com500+
cb
Crunchbase
Founded 2020San Francisco, United States

Funding

$

Estimated Funding

$100K+

Major Investors

Y Combinator, Liquid 2 Ventures, LG Nova, MedTech Innovator

Team (25+)

No team information available.

Company Description

Problem

Managing cardiac patients with heart rhythm disorders often requires frequent monitoring using devices like mobile ECGs and implantable monitors, which can be cumbersome and generate a high volume of data. Clinicians face challenges in efficiently analyzing this data to derive actionable insights and personalize treatment plans. Current remote patient monitoring solutions may not fully integrate with clinical workflows or provide therapeutic guidance.

Solution

SafeBeat Rx offers a mobile platform that leverages artificial intelligence to streamline remote patient monitoring and enhance cardiac care. The platform integrates data from third-party FDA-cleared cardiac monitoring devices, including mobile ECGs, mobile cardiac telemetry, and implantable cardiac monitors. SafeBeat's AI algorithms analyze the data to provide clinicians with actionable insights and treatment recommendations, facilitating efficient patient management and improved access to care. The technology is designed to integrate into existing clinical workflows, offering explainable AI and customized tools that recommend treatment steps tailored to the patient.

Features

AI-powered analysis of data from mobile ECGs, mobile cardiac telemetry, and implantable cardiac monitors

Mobile platform designed for use on smartphones

Explainable AI that provides clinicians with clear insights and treatment recommendations

Software-enabled remote therapeutic monitoring (RTM)

Streamlined workflow integration to enhance patient monitoring and generate billing opportunities

Target Audience

The primary target audience includes cardiologists, electrophysiologists, and other healthcare providers involved in the management of patients with heart rhythm disorders.

Want to add first party data to your startup here or get your entry removed? You can edit it yourself by logging in with your company domain.